» Articles » PMID: 31208114

Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Jun 19
PMID 31208114
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Oral submucous fibrosis (OSF) is characterized by abnormal collagen deposition. It is a precancerous disorder and transforms into a malignant tumor in 1.5-15% of all cases. Symptoms include submucous fibrosis, ulceration, xerostomia, a burning sensation, and restricted mouth opening. All of these greatly interfere with patient quality of life. The present review introduces OSF from a molecular perspective and summarizes what is known about its underlying mechanisms, diagnostic biomarkers, and therapeutic interventions. In addition to the aggressive treatment of OSF, its prevention is also important. Future research should, therefore, focus on improving the oral health literacy of the patients susceptible to OSF.

Citing Articles

Predictors of Dysplasia in Oral Submucous Fibrosis: A Retrospective Observational Study.

Shete M, Kamble P, Patil K, Bhagawati B, Brahmankar U, Sharma M Cureus. 2025; 17(2):e78481.

PMID: 40062078 PMC: 11885211. DOI: 10.7759/cureus.78481.


Colchicine in the Management of Oral Submucous Fibrosis - A Systematic Review and GRADE Assessment.

Chellapandian N, Sekizhar V, Ammayappan P, Srivastava K, Nagy A, Kengadaran S J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4289-S4298.

PMID: 40061634 PMC: 11888695. DOI: 10.4103/jpbs.jpbs_1313_24.


VHL ameliorates arecoline-induced oral submucosal fibrosis by promoting HDAC6 ubiquitination and blocking NF-κB pathway.

Sun H, Yang C, Yin X, Chen S, Huang Y, Kuang H Sci Rep. 2025; 15(1):7563.

PMID: 40038412 PMC: 11880343. DOI: 10.1038/s41598-025-91207-5.


Dental pulp stem cells as a novel antifibrotic therapy for oral submucous fibrosis: An in vitro study.

Narvekar S, Baliga S, Angadi P J Oral Biol Craniofac Res. 2025; 15(2):383-389.

PMID: 40034371 PMC: 11872489. DOI: 10.1016/j.jobcr.2025.02.002.


Association of salivary mmp-8 gene polymorphism with its protein expression in oral submucous fibrosis patients.

Qamar R, Khatoon A, Mirza T, Razi A, Khurshid Y Odontology. 2025; .

PMID: 39994129 DOI: 10.1007/s10266-025-01074-9.


References
1.
Cuzzocrea S, Imperatore F, Costantino G, Luongo C, Mazzon E, Scafuro M . Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat. Shock. 2000; 13(3):197-203. DOI: 10.1097/00024382-200003000-00005. View

2.
Haider S, Merchant A, Fikree F, Rahbar M . Clinical and functional staging of oral submucous fibrosis. Br J Oral Maxillofac Surg. 2000; 38(1):12-5. DOI: 10.1054/bjom.1999.0062. View

3.
Jeng J, Ho Y, Chan C, Wang Y, Hahn L, Lei D . Areca nut extract up-regulates prostaglandin production, cyclooxygenase-2 mRNA and protein expression of human oral keratinocytes. Carcinogenesis. 2000; 21(7):1365-70. View

4.
Jeng J, Chang M, Hahn L . Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol. 2001; 37(6):477-92. DOI: 10.1016/s1368-8375(01)00003-3. View

5.
Lee C, Ko Y, Huang H, Chao Y, Tsai C, Shieh T . The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer. 2003; 88(3):366-72. PMC: 2747536. DOI: 10.1038/sj.bjc.6600727. View